CollPlant Biotechnologies Ltd (OPHI) stock
OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
$3.40−0.20 (-5.56%)
Close on Nov 18, 2026Market cap $4.91MP/E –Yield –
CollPlant Biotechnologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$11.48M. The highest annual figure on record is $65.00K in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.48M | – |
| FY2024 | Dec 31, 2024 | -$17.25M | – |
| FY2023 | Dec 31, 2023 | -$7.51M | – |
| FY2022 | Dec 31, 2022 | -$17.10M | -26403.1% |
| FY2021 | Dec 31, 2021 | $65.00K | – |
| FY2020 | Dec 31, 2020 | -$5.60M | – |
| FY2019 | Dec 31, 2019 | -$7.63M | – |
| FY2018 | Dec 31, 2018 | -$4.25M | – |
| FY2017 | Dec 31, 2017 | -$5.96M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -$3.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.41M | – |
| Q2 FY2023 | Jun 30, 2023 | $5.68M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.19M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.91M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.39M | – |
See a number that looks wrong?